Nele Goeyvaerts

Beerse, VLG, Belgium

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 24 publications

Viral Dynamic Model-Informed Dose Selection of Mosnodenvir Prophylaxis against DENV-3 in a Controlled Human Infection Model.

Viral Dynamic Model-Informed Dose Selection of Mosnodenvir Prophylaxis against DENV-3 in a Controlled Human Infection Model.

Journal: Clinical pharmacology and therapeutics

Published: April 02, 2026

Daily Mosnodenvir as Dengue Prophylaxis in a Controlled Human Infection Model.

Daily Mosnodenvir as Dengue Prophylaxis in a Controlled Human Infection Model.

Journal: The New England journal of medicine

Published: November 26, 2025

Daily Mosnodenvir as Dengue Prophylaxis in a Controlled Human Infection Model.

Daily Mosnodenvir as Dengue Prophylaxis in a Controlled Human Infection Model.

Journal: The New England journal of medicine

Published: November 26, 2025

Population pharmacokinetics and pharmacodynamics of canagliflozin in paediatric patients with type 2 diabetes mellitus.

Population pharmacokinetics and pharmacodynamics of canagliflozin in paediatric patients with type 2 diabetes mellitus.

Journal: British journal of clinical pharmacology

Published: October 22, 2025

Estimating the in vivo prophylactic effect of mosnodenvir, a novel dengue antiviral, on DENV-2 infection.

Estimating the in vivo prophylactic effect of mosnodenvir, a novel dengue antiviral, on DENV-2 infection.

Journal: Journal of the Royal Society, Interface

Published: October 03, 2025

Pharmacokinetics, Safety, and Tolerability of Different Maintenance Dose Regimens of Mosnodenvir (JNJ-1802) in Healthy Adult Participants.

Pharmacokinetics, Safety, and Tolerability of Different Maintenance Dose Regimens of Mosnodenvir (JNJ-1802) in Healthy Adult Participants.

Journal: Clinical pharmacology in drug development

Published: April 03, 2025

Population Pharmacokinetics of siRNA JNJ-73763989 in Healthy Participants and Patients With Chronic Hepatitis B.

Population Pharmacokinetics of siRNA JNJ-73763989 in Healthy Participants and Patients With Chronic Hepatitis B.

Journal: Clinical pharmacology and therapeutics

Published: October 17, 2024

Modelling the impact of JNJ-1802, a first-in-class dengue inhibitor blocking the NS3-NS4B interaction, on in-vitro DENV-2 dynamics.

Modelling the impact of JNJ-1802, a first-in-class dengue inhibitor blocking the NS3-NS4B interaction, on in-vitro DENV-2 dynamics.

Journal: PLoS computational biology

Published: July 21, 2023

Population pharmacokinetic/pharmacodynamic models of JNJ-64794964, a toll-like receptor 7 agonist, in healthy adult participants.

Population pharmacokinetic/pharmacodynamic models of JNJ-64794964, a toll-like receptor 7 agonist, in healthy adult participants.

Journal: Antiviral therapy

Published: January 24, 2023

JNJ-73763989 pharmacokinetics and safety: Liver-targeted siRNAs against hepatitis B virus, in Japanese and non-Japanese healthy adults, and combined with JNJ-56136379 and a nucleos(t)ide analogue in patients with chronic hepatitis B.

JNJ-73763989 pharmacokinetics and safety: Liver-targeted siRNAs against hepatitis B virus, in Japanese and non-Japanese healthy adults, and combined with JNJ-56136379 and a nucleos(t)ide analogue in patients with chronic hepatitis B.

Journal: Antiviral therapy

Published: June 13, 2022

Plasma and Liver Pharmacokinetics of the N-Acetylgalactosamine Short Interfering RNA JNJ-73763989 in Recombinant Adeno-Associated-Hepatitis B Virus-Infected Mice.

Plasma and Liver Pharmacokinetics of the N-Acetylgalactosamine Short Interfering RNA JNJ-73763989 in Recombinant Adeno-Associated-Hepatitis B Virus-Infected Mice.

Journal: The Journal of pharmacology and experimental therapeutics

Published: March 24, 2022

Exposure-response analyses of erdafitinib in patients with locally advanced or metastatic urothelial carcinoma.

Exposure-response analyses of erdafitinib in patients with locally advanced or metastatic urothelial carcinoma.

Journal: Cancer chemotherapy and pharmacology

Published: August 23, 2021

Showing 1-12 of 24

Last Updated: 09/26/2026